Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 164 participants.

Also called NCT07751965

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 164 participants (planned count) (from the registry)
Sponsor
  • Ceric Sàrl Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07751965
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07751965. Allocation not applicable; no masking; primary purpose treatment. Start 2026-10-30 (anticipated); primary completion 2027-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR
Acronym
MARVELTAVI
Condition
Aortic Regurgitation
Condition
Aortic Disease
Condition
Calcified Aortic Valve
Intervention (Device)
Myval THV series
Lead sponsor
Ceric Sàrl (class: industry)

Record details

Record id
cardio:ct-nct07751965
Content hash
930c4cb74c9572b357bbdebf22876ba0926e822f5e8168fb0f449593fb3c23cb